Investors in cannabis and psychedelic drugs often talk excitedly about taking a slice of the $20 billion market for opioids and fix a societal addiction crisis along the way.
Now, an under-the-radar drug has joined them as a potential disruptor: kratom https://t.co/nmFO2bvXa6